title: New opportunities for anti-CD20 monoclonal antibody to give a direct punch to the tumor.
authors.affiliation: Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Sciences Centre , Manchester , UK.
authors.forename: Tim M
authors.initials: TM
authors.lastname: Illidge
authors.forename: Eleanor J
authors.initials: EJ
authors.lastname: Cheadle
authors.forename: Jamie
authors.initials: J
authors.lastname: Honeychurch
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism*; D000069283:Rituximab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; C543332:obinutuzumab